Medicare to Cover Obesity Medications with $50 Monthly Copay Through 2027
Medicare will offer beneficiaries access to FDA-approved obesity medications at a $50 monthly copay through 2027, expanding treatment options for a condition affecting 42% of U.S. adults. The policy, announced ... Read More